Articles tagged with “pharmaceutical-m-a”

Sun Pharma $11.75B Organon Acquisition Strategic Analysis

Analyze Sun Pharma's $11.75B acquisition of Organon. This report examines deal mechanics, the women's health portfolio integration, and biosimilars strategy.

35 min read

5/8/2026

sun pharma organon acquisition pharmaceutical m&a women's health portfolio biosimilars specialty generics corporate strategy

Pharma M&A Due Diligence: A Guide to IT System Assessment

An in-depth guide to IT system assessment in pharma M&A due diligence. Covers infrastructure, data, cybersecurity, AI governance, NIS2/CRA compliance, and FDA cybersecurity guidance for 2025-2026 deals.

55 min read

10/17/2025

pharmaceutical m&a it due diligence technology assessment biotech m&a ma integration regulatory compliance cybersecurity due diligence